Name | Cefcapene Pivoxil Hydrochloride Monohydrate |
---|---|
Synonyms |
CEFCAPENE PIVOXIL HYDROCHLORIDE HYDRATE
[(2,2-Dimethylpropanoyl)oxy]methyl (6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-pentenoyl]amino}-3-[(carbamoyloxy)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate hydrochloride hydrate Flomox 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 3-[[(aminocarbonyl)oxy]methyl]-7-[[(2Z)-2-(2-amino-4-thiazolyl)-1-oxo-2-penten-1-yl]amino]-8-oxo-, (2,2-dimethyl-1-oxopropoxy)methyl ester, (6R,7R)-, hydrochloride, hydrate (1:1:1) Cefcapene pivoxil hydrochloride Cefcapene pivoxil hydrochloride monohydrate |
Description | Cefcapene pivoxil hydrochloride hydrate is a prodrug and an orally active 3rd-generation cephalosporin with broad-spectrum of anti-bacterial activity[1]. Cefcapene pivoxil hydrochloride hydrate is used for the study of palmoplantar pustulosis (PPP) and other infectious diseases[2]. |
---|---|
Related Catalog | |
Target |
IC50: bacterial[1] |
In Vivo | Cefcapene pivoxil hydrochloride hydrate (oral administration; 100mg/kg; 4 days) is effective against invasive BLNAR strains in mice lung, it stimates peak antibiotic concentrations of 1 to 2 μg/ml in the blood of mice from 30 to 120 min after intragastric administration[3]. Animal Model: Four-week-old female C57BL/6J mice with bacterial suspension in BSG (1×109 CFU)[3] Dosage: 100 mg/kg Administration: Oral administration; 100mg/kg; 4 days Result: Was against H. influenzae colonization in mouse lung. |
References |
Density | 1.47 g/cm3 |
---|---|
Boiling Point | 888.4ºC at 760 mmHg |
Melting Point | 158-164ºC |
Molecular Formula | C23H32ClN5O9S2 |
Molecular Weight | 622.111 |
Flash Point | 491.1ºC |
Exact Mass | 621.132996 |
PSA | 256.01000 |
LogP | 3.70600 |
Vapour Pressure | 3.51E-32mmHg at 25°C |
Storage condition | 0-10°C |
RTECS | XI0325000 |
---|---|
HS Code | 2941905990 |
HS Code | 2941905990 |
---|